Welcome to our investor pages

Medical technology company Optomed is leading producer of handheld fundus cameras globally.

Current highlights

Half-year report January – June 2026 Half-year report January – June 2026 presentation Annual Report 2025 Optomed as an investment

Key figures

Net sales 17.1 EUR, million
Gross margin 63,6 %
EBITDA -3,5 EUR, million
Equity ratio 75,1 %

Share Price
Nasdaq Helsinki Stock Exchange

Half-year report
January – June 2026

Latest releases

Investor events

Nov 6 - Nov 6, 2026

Interim Report for 1 January – 30 September 2026

Feb 18 - Feb 18, 2027

Financial Statement Bulletin for 1 January – 31 December 2026

May 4 - May 4, 2027

Interim Report for 1 January – 31 March 2027

Aug 12 - Aug 12, 2027

Half-Year Financial Report for 1 January – 30 June 2027

Nov 4 - Nov 4, 2027

Interim Report for 1 January – 30 September 2027

Aug 14 - Aug 14, 2026

Half-Year Financial Report for 1 January – 30 June 2026

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

Business

Complete solutions for screening – in any location.

Strategy

The company has a long-term growth strategy comprising three key paths.

Key Figures

Read the latest key figures.